EGFR and lip and oral cavity carcinoma: According to the current study, recent reports have shown that Paclitaxel inhibited the growth of the oral cancer cell line, tea8113 malignant proliferation, and enhanced tea8113 cell apoptosis through inhibiting the EGFR signaling pathway (Hu et al., 2015).